DLB
Dolby Laboratories, Inc.NYSETechnology$61.79+1.76%OpenMarket Cap: $5.92B
As of 2026-04-06
Valuation
P/E (TTM)
24.62
PEG
—
P/B
2.27
P/S
4.42
EV/EBITDA
14.03
DCF Value
$78.73
FCF Yield
6.4%
Div Yield
2.2%
Margins & Returns
Gross Margin
87.9%
Operating Margin
18.8%
Net Margin
18.0%
ROE
9.3%
ROA
10.5%
ROIC
7.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 2026 | $346.7M | 87.5% | $62.2M | $53.3M | $0.55 | $0.36 |
| Q4 2025 | $307.0M | 87.1% | $29.7M | $49.3M | $0.51 | $0.33 |
| FY 2025 | $1.35B | 88.1% | $265.0M | $255.0M | $2.62 | $1.32 |
| Q3 2025 | $315.5M | 86.1% | $47.6M | $46.1M | $0.48 | $0.33 |
| Q2 2025 | $369.6M | 90.3% | $112.0M | $91.8M | $0.94 | $0.33 |
| Q1 2025 | $357.0M | 88.6% | $85.1M | $67.8M | $0.70 | $0.33 |
| Q4 2024 | $304.8M | 88.8% | $45.1M | $58.6M | $0.61 | $0.30 |
| FY 2024 | $1.27B | 89.0% | $264.7M | $261.8M | $2.69 | $1.20 |
| Q3 2024 | $288.8M | 87.7% | $40.9M | $38.4M | $0.40 | $0.30 |
| Q2 2024 | $364.5M | 89.4% | $106.5M | $97.8M | $1.01 | $0.30 |
| Q1 2024 | $315.6M | 89.8% | $72.3M | $67.0M | $0.69 | $0.30 |
| FY 2023 | $1.30B | 88.3% | $262.8M | $200.7M | $1.96 | $1.08 |